Sign Out
Pregnant Women: Do not administer ORKEDIA to pregnant or possibly pregnant women. If a patient is found to be pregnant during treatment, the patient must discontinue ORKEDIA therapy immediately. In animal studies (rats), placental transfer, high stillbirth index, low live birth index, and low body weight in the offspring were observed (see Contraindications).
Breast-feeding Women: Breast-feeding is not recommended.
In animal study (rats), evocalcet was transferred into breast milk.
In animal study (rats), offspring growth retardation, etc. was observed.
Continue with Google